RadNet delivered strong Q4 2024 results with revenue rising 13.5% to $477.1 million. Adjusted EPS improved to $0.22, reflecting operational efficiency and strategic investments. The company saw an 8.0% increase in procedural volumes, including double-digit growth in MRI, CT, and PET/CT scans. Cash reserves surged to $740 million, positioning RadNet well for future expansion.
Total revenue increased 13.5% year-over-year to $477.1 million.
Adjusted EPS rose to $0.22 from $0.15 in Q4 2023.
Digital Health revenue surged 28.1% to $18.9 million.
Cash balance grew to $740 million, reflecting strong financial health.
RadNet anticipates continued growth in 2025, supported by increased procedural volumes, strategic acquisitions, and expanded digital health offerings.